DTCFF Projected Dividend Yield
Cl A/Defence Therapeutics Inc ( OTCBB : DTCFF )Defence Therapeutics is engaged in the research and development of biological/biosimilar therapeutic drugs targeting cancer and infectious diseases. Co.'s Accum technology takes multitude biological/biosimilar-based pharmaceutical to a bold new frontier by enabling efficient intracellular access to a given biological while maintaining target cell specificity. Co.'s product pipeline focuses on the intracellular access by different type of vaccine (DNA, RNA and protein) and by protein-delivery system such as monoclonal antibody-based therapies. The Accum technology platform is being used for both antibody drug conjugates- and vaccine-related projects. 20 YEAR PERFORMANCE RESULTS |
DTCFF Dividend History Detail DTCFF Dividend News DTCFF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |